Myeloma2018 Session II

 

Genomics 2018 – What Have We Learned?

During session II of Myeloma2018, Yuan Xiao Zhu, PhD, presents on FAM46C, one of the most frequently mutated genes in multiple myeloma, and how it influences disease progression and treatment outcomes.

Presentations
FAM46C and Multiple Myeloma
Yuan Xiao Zhu, PhD
Mayo Clinic, Scottsdale, AZ
8 September, 2018

Yuan Xiao Zhu, PhD, from the Mayo Clinic, Scottsdale, AZ, discusses the role of FAM46C in multiple myeloma.